Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Syria Technology Digest.
Press releases published on July 30, 2025
Datavault AI Melancarkan Pengkomersialan Perusahaan bagi Ejen AI yang Dibangunkan dengan IBM watsonx untuk Pengewangan Data yang Dikuasakan AI
BEAVERTON, Oregon, July 31, 2025 (GLOBE NEWSWIRE) -- melalui IBN – Datavault AI Inc. (Nasdaq: DVLT), peneraju dalam pengalaman, penilaian dan pengewangan data AI, hari ini mengumumkan perluasan pengkomersialan bagi ejen AI utama mereka—DataScore® dan …
Datavault AI 推出以 IBM watsonx 打造的人工智能代理企業級商業化解決方案，實現 AI 推動數據盈利化
比弗頓，俄勒岡州, July 31, 2025 (GLOBE NEWSWIRE) -- 透過 IBN 發佈 – 在 AI 數據體驗、估值與盈利化方面領先在前的 Datavault AI Inc. (Nasdaq: DVLT) 今日宣佈，以 IBM watsonx.ai 構建的旗艦級 AI 代理產品 DataScore® 及 DataValue® 正加速商業化進程。 IBM 亦將在未來數年投入 AI 工程人才及深厚技術專業知識，協助 Datavault 強化產品效益並加快客戶部署速度。 …
NVIDIA Sets Conference Call for Second-Quarter Financial Results
SANTA CLARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- NVIDIA will host a conference call on Wednesday, August 27, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the second quarter of fiscal year 2026, which ended July 27, 2025. The call …
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results …
Bridgehold Launches New AI-Driven Blockchain Forensics Suite Following Endorsement from Cybersecurity Experts
London UK, July 30, 2025 (GLOBE NEWSWIRE) -- Bridgehold reviews are making headlines as the company today announced the launch of its new AI-driven blockchain forensics suite, a timely move that follows official endorsements from top cybersecurity experts …
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
Inoxoft Launches Offline AI Tool for On-Device Text Classification
PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Inoxoft, a custom software development company, has announced the release of WhiteLightning, an open-source CLI tool that enables developers to train and run fast, lightweight text classifiers entirely …
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body …
Duos Technologies Group, Inc. Announces Proposed Public Offering of Common Stock
JACKSONVILLE, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) a provider of adaptive, versatile and streamlined Edge Data Center (“EDC”) solutions tailored to meet evolving needs in any …
Brag House Announces Closing of $15 Million Private Placement
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”) the Gen Z engagement platform operating at the intersection of gaming, college sports, and digital media, announces today that it has closed …
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025
NEW HAVEN, Conn., July 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that management will review financial results from …
Tenable Announces Second Quarter 2025 Financial Results
Revenue of $247.3 million, up 12% year-over-year. Calculated current billings of $238.6 million, up 8% year-over-year. GAAP operating margin of (3)%; Non-GAAP operating margin of 19%. Net cash provided by operating activities of $42.5 million; Unlevered …
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …
SPS Commerce Reports Second Quarter 2025 Financial Results
Company delivers 98th consecutive quarter of topline growth Second quarter 2025 revenue grew 22% and recurring revenue grew 24% from the second quarter of 2024 MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in …
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
SOUTH SAN FRANCISCO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Climb Global Solutions Reports Second Quarter 2025 Results
EATONTOWN, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is …
Applied Digital Reports Fiscal Fourth Quarter and Full Year 2025 Results
DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for high-performance computing (“HPC”) …
IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients
iMDx first dd-PCR assay to combine relative and absolute measurements of dd-cfDNA into single combined score Data show significantly improved positive predictive value (PPV) for graft rejection, which potentially broadens clinical utility for dd-cfDNA with …
Codexis to Report Second Quarter 2025 Financial Results on August 13
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results …
Pulmonx Reports Second Quarter 2025 Financial Results
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2025 …